Smith Joshua D, Harvey Rachel N, Darr Owen A, Prince Mark E, Bradford Carol R, Wolf Gregory T, Else Tobias, Basura Gregory J
University of Michigan Medical School Ann Arbor Michigan U.S.A.
University of Michigan College of Literature Sciences, and the Arts Ann Arbor Michigan U.S.A.
Laryngoscope Investig Otolaryngol. 2017 Nov 11;2(6):380-389. doi: 10.1002/lio2.122. eCollection 2017 Dec.
Paragangliomas of the head and neck and cranial base are typically benign, slow-growing tumors arising within the jugular foramen, middle ear, carotid bifurcation, or vagus nerve proper. The objective of this study was to provide a comprehensive characterization of our institutional experience with clinical management of these tumors and posit an algorithm for diagnostic evaluation and treatment.
This was a retrospective cohort study of patients undergoing treatment for paragangliomas of the head and neck and cranial base at our institution from 2000-2017. Data on tumor location, catecholamine levels, and specific imaging modalities employed in diagnostic work-up, pre-treatment cranial nerve palsy, treatment modality, utilization of preoperative angiographic embolization, complications of treatment, tumor control and recurrence, and hereditary status (ie, succinate dehydrogenase mutations) were collected and summarized.
The mean (SD) age of our cohort was 51.8 (±16.1) years with 123 (63.4%) female patients and 71 (36.6%) male patients. Catecholamine-secreting lesions were found in nine (4.6%) patients. Fifty-one patients underwent genetic testing, with mutations identified in 43 (20 , 13 7 , 1 and ). Observation with serial imaging, surgical extirpation, radiation, and stereotactic radiosurgery were variably employed as treatment approaches across anatomic subsites.
An algorithmic approach to clinical management of these tumors, derived from our longitudinal institutional experience and current empiric evidence, may assist otolaryngologists, radiation oncologists, and geneticists in the care of these complex neoplasms.
头颈部及颅底副神经节瘤通常为良性、生长缓慢的肿瘤,起源于颈静脉孔、中耳、颈动脉分叉处或迷走神经本身。本研究的目的是全面描述我们机构对这些肿瘤临床管理的经验,并提出一种诊断评估和治疗算法。
这是一项对2000年至2017年在我们机构接受头颈部及颅底副神经节瘤治疗的患者进行的回顾性队列研究。收集并总结了肿瘤位置、儿茶酚胺水平、诊断检查中使用的特定影像学检查方法、治疗前颅神经麻痹、治疗方式、术前血管造影栓塞的使用情况、治疗并发症、肿瘤控制和复发情况以及遗传状态(即琥珀酸脱氢酶突变)的数据。
我们队列的平均(标准差)年龄为51.8(±16.1)岁,其中女性患者123例(63.4%),男性患者71例(36.6%)。9例(4.6%)患者发现有分泌儿茶酚胺的病变。51例患者进行了基因检测,其中43例(20例、13例、7例、1例和 例)发现有突变。根据不同解剖部位,分别采用连续影像学观察监测、手术切除、放疗和立体定向放射外科等不同治疗方法。
基于我们长期的机构经验和当前的实证证据得出的这些肿瘤临床管理的算法方法,可能有助于耳鼻喉科医生、放射肿瘤学家和遗传学家对这些复杂肿瘤的治疗。
4级。